Moreover, our data indicated that the expression of IDO correlated with the poor clinical outcome of ESCC patients and are consistent with a previous study that ESCC patients with higher levels of IDO expression had a worse survival rate than patients with lower levels of IDO expression [24]. This evidence concerns the gene IDO1 and esophageal squamous cell carcinoma.